These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18211895

  • 1. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J, Goodson ML, Hong Y, Sarge KD.
    J Biol Chem; 2008 Mar 21; 283(12):7464-9. PubMed ID: 18211895
    [Abstract] [Full Text] [Related]

  • 2. Mel-18 interacts with RanGAP1 and inhibits its sumoylation.
    Zhang J, Sarge KD.
    Biochem Biophys Res Commun; 2008 Oct 17; 375(2):252-5. PubMed ID: 18706886
    [Abstract] [Full Text] [Related]

  • 3. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y, Chung KC.
    J Biol Chem; 2012 May 18; 287(21):17517-17529. PubMed ID: 22467880
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of DNA binding by differential sumoylation of heat shock factors.
    Anckar J, Hietakangas V, Denessiouk K, Thiele DJ, Johnson MS, Sistonen L.
    Mol Cell Biol; 2006 Feb 18; 26(3):955-64. PubMed ID: 16428449
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH, Lussier-Price M, Cappadocia L, Estephan P, Raiola L, Omichinski JG, Aubry M.
    J Biol Chem; 2013 Dec 20; 288(51):36312-27. PubMed ID: 24174529
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT, Fitzgerald ME, Maiti A, Reiter KH, Guzzo CM, Matunis MJ, Drohat AC.
    J Biol Chem; 2014 May 30; 289(22):15810-9. PubMed ID: 24753249
    [Abstract] [Full Text] [Related]

  • 9. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH, Melhuish TA, Wotton D.
    Cell; 2003 Apr 04; 113(1):127-37. PubMed ID: 12679040
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.
    Smith M, Mallin DR, Simon JA, Courey AJ.
    J Biol Chem; 2011 Apr 01; 286(13):11391-400. PubMed ID: 21278366
    [Abstract] [Full Text] [Related]

  • 12. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
    Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A.
    PLoS One; 2014 Apr 01; 9(7):e102957. PubMed ID: 25036361
    [Abstract] [Full Text] [Related]

  • 13. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS, Campbell M, Kung HJ, Chang PC.
    J Vis Exp; 2018 Jan 29; (131):. PubMed ID: 29443041
    [Abstract] [Full Text] [Related]

  • 14. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K, Lee TD, Chen Y.
    J Biol Chem; 2012 May 04; 287(19):15154-63. PubMed ID: 22403398
    [Abstract] [Full Text] [Related]

  • 15. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL, Ulrich HD.
    Biochem J; 2014 Feb 01; 457(3):435-40. PubMed ID: 24224485
    [Abstract] [Full Text] [Related]

  • 16. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S, Mealer RG, Sixt KM, Barrow RK, Usiello A, Snyder SH.
    J Biol Chem; 2010 Jul 02; 285(27):20428-32. PubMed ID: 20424159
    [Abstract] [Full Text] [Related]

  • 17. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL, Kuo HY, Chang CC, Naik MT, Liao PH, Ho CC, Huang TC, Jeng JC, Hsu PH, Tsai MD, Huang TH, Shih HM.
    EMBO J; 2013 Mar 20; 32(6):791-804. PubMed ID: 23395904
    [Abstract] [Full Text] [Related]

  • 18. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A.
    J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659
    [Abstract] [Full Text] [Related]

  • 19. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S, Coste F, Prieu-Serandon P, Mance L, Gaudon V, Garnier N, Castaing B, Suskiewicz MJ.
    J Biol Chem; 2023 Jul 15; 299(7):104870. PubMed ID: 37247759
    [Abstract] [Full Text] [Related]

  • 20. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
    Merrill JC, Melhuish TA, Kagey MH, Yang SH, Sharrocks AD, Wotton D.
    PLoS One; 2010 Jan 20; 5(1):e8794. PubMed ID: 20098713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.